Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 02, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 11,856 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on September 28, 2006, and the Company was advised of it on October 2, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the trust in the same capacity as other employees.
Key Facts for Investor Verification
- Transaction Date: September 28, 2006.
- Shares Transferred: 11,856 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust (GSK Trust).
- Beneficiaries: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Regulatory Basis: Notification made in accordance with Disclosure Rule 3.1.4R(1)(b).